Pharma Journalist - Page 97 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Archeus Technologies Gets FDA Clearance for ART-101 Prostate Cancer Trial

Health Canada Approves Novartis’ KISQALI for High-Risk Early Breast Cancer

Advarra Launches AI Council to Boost Innovation in Clinical Trials

RyboDyn Joins Lilly Gateway Labs to Advance Immunotherapies Targeting Dark Proteome

Yeztugo Becomes First FDA-Approved HIV Prevention with 6-Month Protection

Actio Biosciences Raises $66M in Series B to Advance Genetics-Based Therapies

FNP-223 Receives FDA Fast Track Designation for Progressive Supranuclear Palsy

J&J Seeks FDA Approval of STELARA for Pediatric Crohn’s Disease

Draig Therapeutics Launches with $140M to Tackle Neuropsychiatric Disorders

Dyne’s DYNE-101 Earns FDA Breakthrough Status, Eyes Accelerated DM1 Approval